1359P Lack of Abscopal effect and radiotherapy-induced lymphocyte depletion in advanced non-small cell lung cancer (NSCLC) patients treated with atezolizumab and radiotherapy von Meisel, A., von Moos, R., Haider, A., Holer, L., Hayoz, S., Bengs, S., Treyer, V., Abedian, R., Websky, S., Rothschild, S.I., Hochmair, M.J., Gandara, D.R., Cappuzzo, F., Reck, M., Stenner-Liewen, F., Mark, M.T.

Volltext

2191P Real-world outcomes of patients with malignant pleural mesothelioma (MPM) treated with combination nivolumab and ipilimumab in the first- or later line setting von Schmid, S., Holer, L., Frueh, M., Koster, K-L., Rothschild, S.I., Britschgi, C., Boos, L., Frehner, L., Almeida, S. Cardoso, Metaxas, Y., Mark, M.T., Froesch, P.R., Janthur, W-D., Allemann, A.T., Waibel, C., Mühll-Schill, C. Vonder, Cerciello, F.W.F., Mauti, L.A.

Volltext

1412P SAKK 17/18-ORIGIN trial: Efficacy and safety from a multicenter phase II trial of gemcitabine and atezolizumab in patients with advanced NSCLC progressing on immune checkpoin... von Curioni-Fontecedro, A., Holer, L., Frueh, M., Weindler, S., König, D., Addeo, A., Britschgi, C., Rigutto, A., Waibel, C., Bettini, A., Cerciello, F.W.F., Hiltbrunner, S., Nguyen, D.L., Zellweger, C., Musilova, J., von Moos, R.A.F., Joerger, M.

Volltext

1279P The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT) von Meisel, A., Mark, M.T., Haider, A., Holer, L., Hayoz, S., Gebhard, C., Bengs, S., Hochmair, M.J., Cappuzzo, F., Reck, M., von Moos, R., Stenner-Liewen, F.

Volltext

1051P Radiotherapy (RT) and efficacy of immune checkpoint inhibitors (ICI), chemotherapy (CTx) and chemoimmunotherapy (CIT) in patients with non-small cell lung cancer (NSCLC) von Meisel, A., Mark, M.T., Haider, A., Holer, L., Hayoz, S., Gebhard, C., Bengs, S., Treyer, V., Rothschild, S.I., Hochmair, M.J., Gandara, D.R., Cappuzzo, F., Reck, M., Stenner-Liewen, F., von Moos, R.A.F.

Volltext

431P Neoadjuvant treatment with regorafenib and capecitabine combined with radiotherapy in locally advanced rectal cancer: A multicenter phase Ib trial (RECAP) SAKK 41/16 von Bastian, S., Joerger, M., Baertschi, D., Holer, L., Guckenberger, M., Jochum, W., Koeberle, D., Siebenhüner, A.R., Berger, M.D., Winterhalder, R.C., Largiadèr, C.R., Löffler-Baumann, M., Mosna- Firlejczyk, K., Wicki, A., Fischer Maranta, A., von Moos, R.A.F.

Volltext

MA11.09 SAKK 16/18: Neoadjuvant Chemotherapy, Durvalumab and Immune-Modulatory RT in Stage III(N2) NSCLC. Surgical Interim Analysis von Dorn, P., Holer, L., Lardinois, D., Dutly, A., Karenovics, W., Habicht, J., Lutz, J.A., Gelpke, H., Opitz, I., Haefliger, S., König, D., Früh, M., Addeo, A., Vonder Mühll-Schill, C., Bettini, A., Scheibe, B., Savic Prince, S., Guckenberger, M., Finazzi, T., Rothschild, S.I., Mauti, L.A.

Volltext

268P Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple-negative, EGFR positive breast cancer: A multicenter single arm phase II trial [SAKK 24/14] von Wicki, A., Mamot, C., Hasler-Strub, U., Riniker, S., Li, Q., Holer, L., Baertschi, D., Zaman, K., von Moos, R., Dedes, K.J., Novak, U., Bodmer, A., Ritschard, R., Obermann, E., Ackermann, C.J., Membrez-Antonioli, V., Zuerrer, U., Caspar, C.B., Rochlitz, C., Winterhalder, R.C.

Volltext

First-line chemo-immunotherapy in SCLC: outcomes of a binational real-world study von Moliner, L., Zellweger, N., Schmid, S., Bertschinger, M., Waibel, C., Cerciello, F., Froesch, P., Mark, M., Bettini, A., Häuptle, P., Blum, V., Holer, L., Hayoz, S., Früh, M., Ahmed, S., Bhagani, S., Steele, N., Gray, H.J., Robinson, S.D., Davidson, M., Cox, S., Khalid, T., Geldart, T.R., Nolan, L., Scott, D.C., Hennah, L., Newsom-Davis, T., Rathbone, E., Handforth, C., Denton, A., Merchant, S., Blackhall, F., Mauti, L.A., Califano, R., Rothschild, S.I.

Volltext

66P Real-world data of first-line chemo-immunotherapy for patients with extensive stage SCLC: A multicentre experience from Switzerland and the UK von Moliner, L., Zellweger, N.M., Schmidt, S.M., Waibel, C., Froesch, P.R., Häuptle, P., Blum, V., Holer, L., Frueh, M., Bhagani, S., Gray, H-L.J., Cox, S., Khalid, T., Scott, D.C., Robinson, S.D., Hennah, L., Handforth, C., Mauti, L.A., Califano, R., Rothschild, S.I.

Volltext

Notch signalling drives synovial fibroblast identity and arthritis pathology von Wei, Kevin, Korsunsky, Ilya, Marshall, Jennifer L., Gao, Anqi, Watts, Gerald F. M., Major, Triin, Croft, Adam P., Watts, Jordan, Blazar, Philip E., Lange, Jeffrey K., Thornhill, Thomas S., Filer, Andrew, Raza, Karim, Donlin, Laura T., Siebel, Christian W., Buckley, Christopher D., Raychaudhuri, Soumya, Brenner, Michael B.

Volltext

Tissue-specific enhancer–gene maps from multimodal single-cell data identify causal disease alleles von Sakaue, Saori, Weinand, Kathryn, Isaac, Shakson, Dey, Kushal K., Jagadeesh, Karthik, Kanai, Masahiro, Watts, Gerald F. M., Zhu, Zhu, Brenner, Michael B., McDavid, Andrew, Donlin, Laura T., Wei, Kevin, Price, Alkes L., Raychaudhuri, Soumya

Volltext

Discovery of the binary pulsar PSR B1259-63 in very-high-energy gamma rays around periastron with HESS von AHARONIAN, F, AKHPERJANIAN, A. G, BOLZ, O, BRAUN, I, BREITLING, F, BROWN, A. M, BUSSONS GORDO, J, CHADWICK, P. M, CHOUNET, L.-M, CORNILS, R, COSTAMANTE, L, DEGRANGE, B, AYE, K.-M, DJANNATI-ATAÏ, A, DRURY, L. Oc, DUBUS, G, EMMANOULOPOULOS, D, ESPIGAT, P, FEINSTEIN, F, FLEURY, P, FONTAINE, G, FUCHS, Y, FUNK, S, BAZER-BACHI, A. R, GALLANT, Y. A, GIEBELS, B, GILLESSEN, S, GLICENSTEIN, J. F, GORET, P, HADJICHRISTIDIS, C, HAUSER, M, HEINZELMANN, G, HENRI, G, HERMANN, G, BEILICKE, M, HINTON, J. A, HOFMANN, W, HOLLERAN, M, HARNS, D, DE JAGER, O. C, JOHNSTON, S, KHELIFI, B, KIRK, J. G, KOMIN, Nu, KONOPELKO, A, BENBOW, W, LATHAM, I. J, LE GALLOU, R, LEMIERE, A, LEMOINE-GOUMARD, M, LEROY, N, MARTINEAU-HUYNH, O, LOHSE, T, MARCOWITH, A, MASTERSON, C, MCCOMB, T. J. L, BERGE, D, BERGHAUS, P, BERNLÖHR, K, BOISSON, C

Volltext

Umfang der Unterstützung durch eine Krankenkasse gemäß §66 SGB V: SGB V §66 von LSG Schlesw.-Holst., Beschl. v. 20.3.2015 – L 5 KR 40/15 B ER (SG Schleswig)

Volltext

The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis von Weinand, Kathryn, Sakaue, Saori, Nathan, Aparna, Jonsson, Anna Helena, Zhang, Fan, Watts, Gerald F. M., Al Suqri, Majd, Zhu, Zhu, Rao, Deepak A., Anolik, Jennifer H., Brenner, Michael B., Donlin, Laura T., Wei, Kevin, Raychaudhuri, Soumya

Volltext

Wirtschaftlichkeitsprüfung der Anforderung von Impfstoffen – Zuständigkeit der Prüfungsstelle, quartalsübergreifende Prüfung, Zuschlag von 10% ermessensgerecht: SGB V, AMG von Schlesw.-Holst. LSG, Urt. v. 8.12.2015 – L 4 KA 44/13 (SG Kiel)

Volltext

Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue von Bell, Richard D., Brendel, Matthew, Konnaris, Maxwell A., Xiang, Justin, Otero, Miguel, Fontana, Mark A., Bai, Zilong, Krenitsky, Daria M., Meednu, Nida, Rangel-Moreno, Javier, Scheel-Toellner, Dagmar, Carr, Hayley, Nayar, Saba, McMurray, Jack, DiCarlo, Edward, Anolik, Jennifer H., Donlin, Laura T., Orange, Dana E., Kenney, H. Mark, Schwarz, Edward M., Filer, Andrew, Ivashkiv, Lionel B., Wang, Fei

Volltext

High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership von Carlucci, Philip M, Li, Jessica, Fava, Andrea, Deonaraine, Kristina K, Wofsy, David, James, Judith A, Putterman, Chaim, Diamond, Betty, Davidson, Anne, Fine, Derek M, Monroy-Trujillo, Jose, Atta, Mohamed G, DeJager, Wade, Guthridge, Joel M, Haag, Kristin, Rao, Deepak A, Brenner, Michael B, Lederer, James A, Apruzzese, William, Belmont, H Michael, Izmirly, Peter M, Zaminski, Devyn, Wu, Ming, Connery, Sean, Payan-Schober, Fernanda, Furie, Richard, Dall'Era, Maria, Cho, Kerry, Kamen, Diane, Kalunian, Kenneth, Anolik, Jennifer, Barnas, Jennifer, Ishimori, Mariko, Weisman, Michael H, Buyon, Jill P, Petri, Michelle

Volltext

Pflegebedarf und Sachleistungsprinzip bei Eingliederungshilfe: SGB XII §55 von LSG Schlesw.-Holst., Beschl. v. 21.12.2012 – L 9 SO 151/12 B ER (SG Schleswig)

Volltext

Vor- und nachstationäre Behandlung im Krankenhaus: SGB V §§115a Abs. 1 S. 1 Nr. 1 Alt. 1, 39, 115 Abs. 1 u. Abs. 2 S. 1 Nr. 4 von LSG Schlesw-Holst., Urt. v. 9.2.2012 – L 5 KR 52/11 (LG Lübeck) (nicht rechtskräftig)

Volltext